Bouattour Yassine, Chennell Philip, Wasiak Mathieu, Jouannet Mireille, Sautou Valérie
CHU Clermont-Ferrand, Pôle Pharmacie, Clermont-Ferrand, France.
Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, SIGMA Clermont-Ferrand, ICCF, Clermont-Ferrand, France.
PeerJ. 2018 Apr 18;6:e4549. doi: 10.7717/peerj.4549. eCollection 2018.
Polyhexamethylene biguanide (PHMB) eye drops are a frequently used medication to treat Acanthamoeba keratitis. In the absence of marketed PHMB eye drops, pharmacy-compounding units are needed to prepare this much needed treatment, but the lack of validated PHMB stability data severely limits their conservation by imposing short expiration dates after preparation. In this study we aim to assess the physicochemical and microbiological stability of a 0.2 mg/mL PHMB eye drop formulation stored in two kinds of polyethylene bottles at two different temperatures.
A liquid chromatography coupled with diode array detector stability-indicating method was validated to quantify PHMB, using a cyanopropyl bonded phase (Agilent Zorbax Eclipse XDB-CN column 4.6 × 75 mm with particle size of 3.5 μm) and isocratic elution consisting of acetonitrile/deionized water (3/97 v/v) at a flow rate of 1.3 mL/min. PHMB eye drops stability was assessed for 90 days of storage at 5 and 25 °C in ethylene oxide sterilized low density polyethylene (EOS-LDPE) and gamma sterilized low density polyethylene (GS-LDPE) bottles. The following analyses were performed: visual inspection, PHMB quantification and breakdown products (BPs) screening, osmolality and pH measurements, and sterility assessment. PHMB quantification and BP screening was also performed on the drops emitted from the multidose eyedroppers to simulate in-use condition.
The analytical method developed meets all the qualitative and quantitative criteria for validation with an acceptable accuracy and good linearity, and is stability indicating. During 90 days of storage, no significant decrease of PHMB concentration was found compared to initial concentration in all stored PHMB eye drops. However, BP were found at day 30 and at day 90 of monitoring in both kind of bottles, stored at 5 and 25 °C, respectively. Although no significant variation of osmolality was found and sterility was maintained during 90 days of monitoring, a significant decrease of pH in GS-LDPE PHMB eye drops was noticed reaching 4 and 4.6 at 25 °C and 5 °C respectively, compared to initial pH of 6.16.
Although no significant decrease in PHMB concentration was found during 90 days of monitoring in all conditions, the appearance of BPs and their unknown toxicities let us believe that 0.2 mg/mL PHMB solution should be conserved for no longer than 60 days in EOS-LDPE bottles at 25 °C.
聚六亚甲基双胍(PHMB)滴眼液是治疗棘阿米巴角膜炎常用的药物。由于市场上没有PHMB滴眼液出售,需要药房配制单位来制备这种急需的治疗药物,但缺乏经过验证的PHMB稳定性数据,通过规定制备后的有效期较短,严重限制了其保存。在本研究中,我们旨在评估储存在两种聚乙烯瓶中、处于两种不同温度下的0.2mg/mL PHMB滴眼液制剂的物理化学稳定性和微生物稳定性。
采用液相色谱结合二极管阵列检测器的稳定性指示方法对PHMB进行定量分析,使用氰丙基键合相(安捷伦Zorbax Eclipse XDB-CN柱,4.6×75mm,粒径3.5μm),以乙腈/去离子水(3/97 v/v)进行等度洗脱,流速为1.3 mL/min。在环氧乙烷灭菌的低密度聚乙烯(EOS-LDPE)瓶和γ射线灭菌的低密度聚乙烯(GS-LDPE)瓶中,于5℃和25℃储存90天,评估PHMB滴眼液的稳定性。进行了以下分析:外观检查、PHMB定量和分解产物(BPs)筛查、渗透压和pH测量以及无菌评估。还对多剂量滴管挤出的滴眼液进行了PHMB定量和BP筛查,以模拟使用情况。
所建立的分析方法符合验证的所有定性和定量标准,具有可接受的准确性和良好的线性,且为稳定性指示方法。在90天的储存期内,与所有储存的PHMB滴眼液的初始浓度相比,未发现PHMB浓度有显著下降。然而,分别在5℃和25℃储存的两种瓶子中,在监测的第30天和第90天均发现了BP。虽然在90天的监测期内未发现渗透压有显著变化且保持了无菌状态,但与初始pH 6.16相比,GS-LDPE PHMB滴眼液的pH在25℃和5℃时分别显著下降至4和4.6。
尽管在所有条件下90天的监测期内未发现PHMB浓度有显著下降,但BP的出现及其未知毒性使我们认为,0.2mg/mL PHMB溶液在25℃的EOS-LDPE瓶中保存不应超过60天。